Epizyme is a biopharmaceutical company that develops and commercializes novel epigenetic therapeutics for the treatment of blood cancer and tumors.Read more
Constellation is Epizyme's #1 competitor. Constellation is a Public company that was founded in 2008 in Cambridge, Massachusetts. Constellation is in the Pharmaceuticals industry. Compared to Epizyme, Constellation has 30 more employees.
Secura Bio is seen as one of Epizyme's biggest rivals. Secura Bio was founded in Las Vegas, Nevada} in 2018. Secura Bio competes in the Health Care Services field. Compared to Epizyme, Secura Bio generates $10.3M less revenue.
Epizyme's revenue is the ranked 12th among it's top 10 competitors. The top 10 competitors average 2.6B. Over the last four quarters, Epizyme's revenue has grown by 3175.1%. Specifically, in Q1 2021's revenue was $7.6M; in Q4 2020, it was $2.5M; in Q3 2020, it was $ < 1M; in Q2 2020, Epizyme's revenue was $ < 1M.
No recent acquisitions found related to Epizyme
No recent investments found related to Epizyme